Metlife Inc (NYSE:MET)’s traded shares stood at 0.62 million during the latest session, with the company’s beta value hitting 0.84. At the last check today, the stock’s price was $77.14, to imply a decrease of -0.98% or -$0.76 in intraday trading. The MET share’s 52-week high remains $89.05, putting it -15.44% down since that peak but still an impressive 15.47% since price per share fell to its 52-week low of $65.21.
Analysts have given a consensus recommendation of Buy for Metlife Inc (MET), translating to a mean rating of 1.70. Of 9 analyst(s) looking at the stock, 0 analyst(s) give MET a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 9 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 2.33.
Metlife Inc (NYSE:MET) trade information
After registering a -0.98% downside in the latest session, Metlife Inc (MET) has traded red over the past five days. The 5-day price performance for the stock is -4.13%, and 3.91% over 30 days. With these gigs, the year-to-date price performance is -5.79%.
The extremes give us $94 and $109 for target low and target high price respectively. As such, MET has been trading -41.3% off suggested target high and -21.86% from its likely low.
Metlife Inc (MET) estimates and forecasts
The rating firms project that company’s revenue will grow 2.69% compared to the previous financial year.
Revenue forecast for the current quarter as set by 4 analysts is 18.35B. Meanwhile, for the current quarter, a total of 4 analyst(s) estimate revenue growth to 18.53B.Earnings reports from the last fiscal year show that sales brought in 18.68B and 17.61B respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -1.79% before jumping 5.20% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -0.38% for the past 5-year period. While 2025 is set for a 12.46% return in earnings, projections for the next 5 years are at 11.87% annually.
MET Dividends
Metlife Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Metlife Inc has a forward dividend ratio of 2.20, with the share yield ticking at 2.86% to continue the rising pattern observed over the past year.
The next major institution holding the largest number of shares is DODGE & COX with 56.35 million shares, or about 7.9315% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $3.96 billion.
We also have Dodge & Cox Funds-Dodge & Cox Stock Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Metlife Inc (MET) shares. Going by data provided on Dec 31, 2024 , Dodge & Cox Funds-Dodge & Cox Stock Fund holds roughly 39.74 shares. This is just over 5.92% of the total shares, with a market valuation of $3.07 billion. Data from the same date shows that the other fund manager holds a little less at 18.42, or 2.74% of the shares, all valued at about 1.42 billion.
